Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Woman, over 18 years old.~2. With non-metastatic breast cancer.~3. Treated by hormone therapy, regardless of the molecule (cancer RH positive).~4. In primary prescription of hormone therapy.~5. First prescription by a medical oncologist, surgeon or radiation therapist from the CGFL.~6. Pharmacy of the patient located in the perimeter defined in the context of the study (Residents in the Burgundy region between a triangle delimited by the towns of Chatillon sur Seine, Dole and Chalon sur Saone.~7. Woman who received information about the study and gave her written consent.~8. Affiliation to a social security scheme.~9. Participant Agreement of the referent city pharmacy of the patient.~Exclusion Criteria:~1. Metastatic patient.~2. Patient participating in another epidemiological or clinical study of adherence and / or hormone therapy.~3. Patient under guardianship, curatorship or safeguard of justice.~4. Patient with severe psychiatric disorders or who does not speak the French language~5. Refusal to participate in the study.~6. Refusal of participation of the referent city pharmacy of the patient.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pharmaceutical Interview (Type: EXPERIMENTAL): Pharmaceutical Interview to motivate patient in his hormonotherapy's compliance

Based on this trial design, predict the completion outcome and termination type (if applicable).